A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adult Subjects with a History of Ragweed Induced

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/09 → 9/30/11

Funding

  • Schering Plough Co: $120,061.00